Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CA125 and anti-HER2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two factors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY